Jeevan Scientific Promoters Acquire 30L Warrants in Preferential Allotment

Jeevan Scientific Technology has received multiple SEBI disclosure filings from four promoters regarding the acquisition of 30,00,000 convertible warrants through preferential allotment. All transactions were completed on January 2, with disclosures filed under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Warrant Acquisition Details

Four promoters of the company acquired convertible warrants through preferential issue, representing a coordinated strategic move to increase their stakes through convertible instruments. Krishna Kishore Kuchipudi, Managing Director, led the acquisitions with the largest warrant holding.

Promoter:	Designation	Warrants Acquired	Diluted Stake Impact
Krishna Kishore Kuchipudi:	Managing Director	12,00,000	5.12%
Vanaja Kuchipudi:	Promoter	6,00,000	2.56%
Jeevan Krishna Kuchipudi:	Non-Executive Director	6,00,000	2.56%
Snigdha Mothukuri:	Executive Director	6,00,000	2.56%
Total Warrants:		30,00,000	12.80%

Individual Shareholding Changes

The acquisitions have resulted in significant changes to each promoter's overall shareholding pattern in the company. While equity shareholdings remain unchanged, the addition of convertible warrants substantially increases their potential diluted stakes.

Promoter:	Equity Shares	Pre-Acquisition %	Post-Acquisition Diluted %	Total Change
Krishna Kishore Kuchipudi:	21,35,113	13.48%	14.24%	+0.76%
Vanaja Kuchipudi:	15,73,800	9.93%	9.28%	-0.65%
Jeevan Krishna Kuchipudi:	9,17,772	5.79%	6.48%	+0.69%
Snigdha Mothukuri:	78,500	0.49%	2.90%	+2.41%

Share Capital Structure Impact

The preferential allotment of convertible warrants significantly affects the company's potential diluted share capital structure. The company's equity capital has increased from ₹15.83 crores to ₹19.92 crores, with substantial potential for further expansion upon warrant conversion.

Capital Structure:	Before Allotment	After Allotment	Post-Conversion Potential
Equity Capital:	₹15.83 crores	₹19.92 crores	₹23.42 crores
Total Shares:	1,58,33,965	1,99,18,965	2,34,18,965
Face Value:	₹10.00	₹10.00	₹10.00
Warrant Impact:	-	40,85,000 shares	35,00,000 warrants

Regulatory Compliance

All disclosures confirm that the acquirers belong to the promoter group of Jeevan Scientific Technology Limited. The filings were submitted to BSE Limited, where the company's shares are listed under scrip code 538837. All regulatory requirements under SEBI takeover regulations have been fulfilled through these comprehensive disclosures, ensuring transparency in the substantial acquisition of convertible instruments by the promoter group.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-2.01%	+13.25%	+16.46%	+72.94%	+43.00%	+113.14%

Jeevan Scientific Technology Limited has announced a strategic acquisition of a 60% stake in M/s. Naya Pharma Private Limited for ₹10.00 crores, as disclosed in a regulatory filing under Regulation 30 of SEBI (LODR) Regulations, 2015. The acquisition represents a significant step in the company's diversification and expansion strategy into the pharmaceutical sector.

Acquisition Structure and Funding

The acquisition will be funded through proceeds raised from the preferential issue approved by shareholders in an Extraordinary General Meeting. The company had approved the issue and allotment of 35,00,000 convertible warrants to Promoters and Non-Promoters, along with 41,85,000 equity shares to Non-Promoters.

Parameter	Details
Acquisition Cost	₹10.00 crores
Funding Source	Preferential issue proceeds
Shareholding to be Acquired	60% on post-issue paid capital
Acquisition Timeline	Different tranches from time to time
Consideration Type	Cash

Target Company Profile

Naya Pharma Private Limited was incorporated on August 19, 2020, and operates in the pharmaceutical manufacturing sector. The company has a current paid-up capital of ₹3,66,70,330, divided into 36,67,033 equity shares of ₹10.00 each.

Company Details	Information
Incorporation Date	August 19, 2020
Paid-up Capital	₹3,66,70,330
Number of Shares	36,67,033 equity shares
Face Value	₹10.00 per share
Industry Sector	Pharma Sector

Business Operations and Synergies

Naya Pharma's business objects include manufacturing, production, buying, selling, importing, exporting, trading, and dealing in Active Pharmaceutical Ingredients (bulk drugs), Drug Intermediates, Organic and Inorganic chemicals, Fine Chemicals, and Dye Pigments both in India and abroad. This acquisition aligns with Jeevan Scientific's diversification strategy and creates synergy for the clinical trials business undertaken by the acquiring company.

Related Party Transaction Details

The acquisition qualifies as a related party transaction, as Mrs. Snigdha Mothukuri and Mrs. K. Vanaja are shareholders holding 100% shareholding in Naya Pharma. These individuals are also promoters of Jeevan Scientific Technology Limited. Additionally, Mr. K. Krishna Kishore and Mrs. Snigdha Mothukuri serve as common directors on the boards of both the investing and investee companies. Currently, Jeevan Scientific has three directors: Mr. K. Krishna Kishore, Mrs. Snigdha Mothukuri, and Mrs. K. Vanaja.

Regulatory Compliance

The company has confirmed that no governmental or regulatory approvals are required for this acquisition. The disclosure has been made in compliance with the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.